IonQ Total Cost of Revenue increased by 13.0% to $49.25M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1041.5%, from $4.32M to $49.25M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 193.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $327.00K | $234.00K | $298.00K | $568.00K | $742.00K | $733.00K | $901.00K | $1.04M | $1.90M | $2.01M | $3.16M | $3.41M | $5.62M | $6.52M | $5.05M | $4.32M | $8.33M | $21.25M | $43.59M | $49.25M |
| QoQ Change | — | -28.4% | +27.4% | +90.6% | +30.6% | -1.2% | +22.9% | +15.0% | +83.5% | +5.6% | +57.5% | +7.9% | +64.7% | +15.9% | -22.6% | -14.5% | +93.0% | +155.2% | +105.1% | +13.0% |
| YoY Change | — | — | — | — | +126.9% | +213.2% | +202.3% | +82.4% | +156.2% | +173.9% | +251.1% | +229.5% | +195.8% | +224.5% | +59.5% | +26.4% | +48.1% | +226.2% | +764.1% | >999% |